Pharmaterials are delighted to announce the appointment of Dr Stephen Watt as Director of Screening. Stephen worked in the Pfizer Institute, University of Cambridge, on amorphous materials, before working in salt selection, screening and co-crystal formation at a CRO. He is leaving a position at Glaxo SmithKline where he is responsible for candidiate selection.
Professor Graham Buckton said "We have a state-of-the-art screening facility and are producing top quality results. It is a great boost to this endeavour to have a scientist with Stephen's experience and qualities join the organisation. The rapid growth in this area of activity will continue with further investment in staff and instrumentation, all of which will benefit our existing and future clients". |
